未找到相关数据
Clinical treatment score post-5 years (CTS5) and the prediction of survival benefit from extended endocrine therapy for breast cancer patients under and over 50 years of age
被引：1
作者：
Ahn, Jee Hyun
Park, Jung Min
Choi, Soon Bo
Go, Jieon
Kim, Jee Ye
Park, Hyung Seok
Kim, Seung Il
Park, Byeong-Woo
Park, Seho
机构：
关键词：
Selective Estrogen Receptor Modulators;
Aromatase Inhibitors;
Breast Neoplasm;
Clinical Decision Rules;
Survival analysis;
D O I：
10.1158/1538-7445.SABCS21-P1-07-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-07-03
引用
收藏
页数：2
相关论文